Yazici, D. Et Al. 2005. ACE inhibition decreases asymmetrical dimethylarginine levels and improves endothelial function in type 1 diabetic patients. 65th Annual Meeting of the American-Diabetes-Association , (California, United States Of America).

Yazici, D., Yavuz, D., Unsalan, S., Toprak, A., Deyneli, O., Yuksel, M., ... Aydin, H.(2005). ACE inhibition decreases asymmetrical dimethylarginine levels and improves endothelial function in type 1 diabetic patients . 65th Annual Meeting of the American-Diabetes-Association, California, United States Of America

Yazici, D Et Al. "ACE inhibition decreases asymmetrical dimethylarginine levels and improves endothelial function in type 1 diabetic patients," 65th Annual Meeting of the American-Diabetes-Association, California, United States Of America, 2005

Yazici, D Et Al. "ACE inhibition decreases asymmetrical dimethylarginine levels and improves endothelial function in type 1 diabetic patients." 65th Annual Meeting of the American-Diabetes-Association , California, United States Of America, 2005

Yazici, D. Et Al. (2005) . "ACE inhibition decreases asymmetrical dimethylarginine levels and improves endothelial function in type 1 diabetic patients." 65th Annual Meeting of the American-Diabetes-Association , California, United States Of America.

@conferencepaper{conferencepaper, author={D Yazici Et Al. }, title={ACE inhibition decreases asymmetrical dimethylarginine levels and improves endothelial function in type 1 diabetic patients}, congress name={65th Annual Meeting of the American-Diabetes-Association}, city={California}, country={United States Of America}, year={2005}}